Tuesday, 22nd January 2019
Cell Biology and Immunology

     Role of the epithelial to mesenchymal transition of mesothelial cells in fibrosis and cancer.

 

 

grupo-400
 

 


 

 

Manuel López Cabrera

 ASciStaff

APublications

 

 

 

 

Research summary:

We have demonstrated that peritoneal mesothelial cells undergo an epithelial-to-mesenchymal transition (EMT) in response to dialysis. Transdifferentiated mesothelial cells acquire myofibroblastic characteristics and are capable of invading the submesothelialstroma, where they produce large amounts of extracellular matrix, as well as angiogenic and inflammatory factors, thus favouring the processes that lead to membrane failure. Our data suggest that the EMT of mesothelial cells is a good marker of membrane failure and could be a therapeutic target to prevent PD-induced fibrosis and/or angiogenesis.

 

 

 

     
  fig01-300   ---- fig02-300  ----

In the peritoneum new fibroblast-like cells arise from local conversion of mesothelial cells (MCs) by epithelial to mesenchymal transition (EMT) during peritoneal dialysis. Trans-differentiated MCs invade the submesothelialstroma, where they participate in the fibrotic and angiogenic processes, which ultimately lead to peritoneal ultrafiltration failure.

 

 

 

 

 

 

 

 

 

 

 

 

Peritoneal dissemination is a frequent metastatic route for cancers of the ovary and gastrointestinal tract.We have shown that in peritoneal metastatic implants a sub-population of carcinoma-associated fibroblasts (CAFs) derives from mesothelial cells through mesothelial to mesenchymal transition (MMT). Moreover, MMT promotes the adhesion and invasion of tumor cells.

 

 

 

 

 

 

Furthermore, characterization of the EMT process of mesothelial cells has opened a new line of research for our group, which consists of analyzing the role of transdifferentiation of mesothelial cells in the intraperitoneal implantation and growth of metastatic tumors. Cancer-associated fibroblasts (CAFs) participate in all stages of tumor progression. However, the origin of CAFs has not been clearly established. Our group is trying to demonstrate that in the case of peritoneal metastasis, CAFs may also derive from mesothelial cells via EMT. The fact that mesothelial cells that have undergone EMT produce large amounts of the pro-angiogenic factor VEGF suggests that these cells may play an important role in tumour vascularisation and growth.

The aim of this our work is to expand the knowledge of the pathological implications of the EMT of mesothelial cells and the molecular mechanisms that regulate this process, and to identify molecular targets for the design of therapeutic strategies, with possible applications in diseases associated with peritoneal fibrosis/angiogenesis, and in peritoneal metastasis.


 

Relevant publications:

1.-Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.
Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizcaíno P, Pérez-Lozano ML, Ruiz-Carpio V, Majano PL, Lamas S, Rodríguez-Pascual F, Borras-Cuesta F, Dotor J, López-Cabrera M.
J Am Soc Nephrol. 2011 Sep;22(9):1682-95

2.- Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation.
Molina-Jiménez F, Benedicto I, Murata M, Martín-Vílchez S, Seki T, Antonio Pintor-Toro J, Tortolero M, Moreno-Otero R, Okazaki K, Koike K, Barbero JL, Matsuzaki K, Majano PL, López-Cabrera M.
Hepatology. 2010 Mar;51(3):777-87.

3.- Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane.
Aroeira LS, Lara-Pezzi E, Loureiro J, Aguilera A, Ramírez-Huesca M, González-Mateo G, Pérez-Lozano ML, Albar-Vizcaíno P, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, Selgas R, López-Cabrera M.
J Am Soc Nephrol. 2009 Mar;20(3):582-92.

4.- Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
Aroeira LS, Aguilera A, Sánchez-Tomero JA, Bajo MA, del Peso G, Jiménez-Heffernan JA, Selgas R, López-Cabrera M.
J Am Soc Nephrol. 2007 Jul;18(7):2004-13.

5.- Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.
Yáñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, Aguilera A, Sánchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sánchez-Madrid F, López-Cabrera M.
N Engl J Med. 2003 Jan 30;348(5):403-13.


 

Doctoral theses:

Guadalupe Tirma González Mateo (2011). Caracterización y modulación de la inflamación peritoneal para limitar la fibrosis causada por el líquido de diálisis: modelo de ratón. Universidad Complutense de Madrid. Director: Manuel López Cabrera y Rafael Selgas Gutiérrez.

Ignacio Benedicto Español (2011). Interrelación entre proteínas asociadas a uniones intercelulares estrechas, polaridad de los hepatocitos y el virus de la hepatitis C. Universidad Autónoma de Madrid. Directores: Manuel López Cabrera y Pedro Lorenzo Majano Rodríguez.

Jesús Loureiro Álvarez (2011). Transición epitelio-mesenquimal como diana terapéutica en modelos experimentales de diálisis peritoneal. Universidad Autónoma de Madrid. Director: Manuel López Cabrera.

 

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

COOKIES POLICY

What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: